Cite
HARVARD Citation
Yip, K. et al. (n.d.). 62: A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England. Lung cancer. pp. S28-S29. [Online].